25 related articles for article (PubMed ID: 30579596)
1. CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1.
Ma M; Wang C; Wu M; Gu S; Yang J; Zhang Y; Cheng S; Xu S; Zhang M; Wu Y; Zhao Y; Tian X; Voon DC; Takahashi C; Sheng J; Wang Y
Cell Oncol (Dordr); 2023 Dec; ():. PubMed ID: 38082211
[TBL] [Abstract][Full Text] [Related]
2. ChGn-2 Plays a Cardioprotective Role in Heart Failure Caused by Acute Pressure Overload.
Haryono A; Ikeda K; Nugroho DB; Ogata T; Tsuji Y; Matoba S; Moriwaki K; Kitagawa H; Igarashi M; Hirata KI; Emoto N
J Am Heart Assoc; 2022 Apr; 11(7):e023401. PubMed ID: 35322673
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin Sulfate/Dermatan Sulfate-Protein Interactions and Their Biological Functions in Human Diseases: Implications and Analytical Tools.
Zhang B; Chi L
Front Cell Dev Biol; 2021; 9():693563. PubMed ID: 34422817
[TBL] [Abstract][Full Text] [Related]
4. Macrophages bind LDL using heparan sulfate and the perlecan protein core.
Ng CY; Whitelock JM; Williams H; Kim HN; Medbury HJ; Lord MS
J Biol Chem; 2021; 296():100520. PubMed ID: 33684447
[TBL] [Abstract][Full Text] [Related]
5. Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis.
Anggraeni VY; Emoto N; Yagi K; Mayasari DS; Nakayama K; Izumikawa T; Kitagawa H; Hirata K
Biochem Biophys Res Commun; 2011 Mar; 406(1):36-41. PubMed ID: 21284936
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin Sulfate
Adhikara IM; Yagi K; Mayasari DS; Suzuki Y; Ikeda K; Ryanto GRT; Sasaki N; Rikitake Y; Nadanaka S; Kitagawa H; Miyata O; Igarashi M; Hirata KI; Emoto N
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1076-1091. PubMed ID: 33504177
[TBL] [Abstract][Full Text] [Related]
7. GlcUAβ1-3Galβ1-3Galβ1-4Xyl(2-O-phosphate) is the preferred substrate for chondroitin N-acetylgalactosaminyltransferase-1.
Izumikawa T; Sato B; Mikami T; Tamura J; Igarashi M; Kitagawa H
J Biol Chem; 2015 Feb; 290(9):5438-48. PubMed ID: 25568321
[TBL] [Abstract][Full Text] [Related]
8. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
[TBL] [Abstract][Full Text] [Related]
9. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
10. Chondroitin sulfate N-acetylgalactosaminyltransferase-2 deletion alleviates lipoprotein retention in early atherosclerosis and attenuates aortic smooth muscle cell migration.
Adhikara IM; Yagi K; Mayasari DS; Ikeda K; Kitagawa H; Miyata O; Igarashi M; Hatakeyama K; Asada Y; Hirata KI; Emoto N
Biochem Biophys Res Commun; 2019 Jan; 509(1):89-95. PubMed ID: 30579596
[TBL] [Abstract][Full Text] [Related]
11. Smooth Muscle Cell-Proteoglycan-Lipoprotein Interactions as Drivers of Atherosclerosis.
Allahverdian S; Ortega C; Francis GA
Handb Exp Pharmacol; 2022; 270():335-358. PubMed ID: 33340050
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
